Backaap Implantate AG Overview

aap Implantate AG EBIT

aap Implantate AG's EBIT is $-2.8M, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$516.10K
↓ 6.08% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$2.77M
↑ 5.38% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

aap Implantate AG (AAQ1.DE) FAQ

The latest EBIT for AAQ1.DE is $-2.8M as of June 2026. That compares with $-2.9M in the prior-year period — up 5.4% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside aap Implantate AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, AAQ1.DE's EBIT moved from $-2.9M to $-2.8M — a 5.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in aap Implantate AG's operating scale or balance-sheet position.

Against its sector companies, AAQ1.DE currently prints $-2.8M for EBIT, while the sector average sits near $2.3T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at aap Implantate AG's growth, margins, and balance sheet.

A EBIT figure of $-2.8M for AAQ1.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.

After noting AAQ1.DE's EBIT ($-2.8M), review year-over-year change from $-2.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers